amiodarone has been researched along with Amyloidosis in 1 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Amyloidosis: A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nakazawa, T | 1 |
Murata, S | 1 |
Kondo, T | 1 |
Nakamura, N | 1 |
Yamane, T | 1 |
Iwasa, S | 1 |
Katoh, R | 1 |
1 other study available for amiodarone and Amyloidosis
Article | Year |
---|---|
Histopathology of the thyroid in amiodarone-induced hypothyroidism.
Topics: Aged; Amiodarone; Amyloidosis; Anti-Arrhythmia Agents; Female; Humans; Hypothyroidism; Multiple Myel | 2008 |